Effectiveness of mepolizumab in patients switching from prior biologic treatments for severe asthma: a post hoc analysis of the NUCALA Effectiveness Study (NEST).

Xolair (omalizumab) - Roche, Novartis

Nucala (mepolizumab) - GSK

http://www.ncbi.nlm.nih.gov/pubmed/42752293

Alejandra Galeano Mesa; Bassam Mahboub; Elizabeth García; Emilio Feres; Gur Levy; Mona Al-Ahmad; Nasser Al Busaidi; Riyad Omar Al-Lehebi; Saeed Noibi; Seema Haider; Sevim Bavbek; Tayseer Ibrahim; Venkata Nagarjuna Maturu

Sep 18, 2026